adthera bio
Matt Symes is currently serving as the Head of Strategy & Finance at adthera bio. Prior to this role, they held positions at Delin Ventures and Boston Consulting Group, where they focused on quantitative analysis, modelling, healthcare in Africa, and private equity. Matt also worked as a Financial Analyst at Genasys and completed degrees in Actuarial Science at Stellenbosch University.
This person is not in any teams
adthera bio
We are a highly experienced digital first company focused exclusively on cell and gene therapy process development and manufacturing. We are the partner of choice in high quality GxP development and manufacturing in Advanced Therapy Medicinal Products. We take your cell therapy ideas and make them into workable medical interventions for patients, all in a regulatory compliant and quality managed system, to get it right first time. Based on brilliant ideas and curious capable minds, we partner with biotechs and academic centres to bring novel ATMP therapies to market and thus to patients who urgently need them. We have highly personalised approaches from the patient to the client to the treatment outcome.